David Kirn

2022

In 2022, David Kirn earned a total compensation of $3.3M as Chief Executive Officer at 4D Molecular Therapeutics, a 37% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$321,750
Option Awards$2,367,000
Salary$585,720
Other$13,500
Total$3,287,970

Kirn received $2.4M in option awards, accounting for 72% of the total pay in 2022.

Kirn also received $321.8K in non-equity incentive plan, $585.7K in salary and $13.5K in other compensation.

Rankings

In 2022, David Kirn's compensation ranked 1,103rd out of 5,732 executives tracked by ExecPay. In other words, Kirn earned more than 80.8% of executives.

ClassificationRankingPercentile
All
1,103
out of 5,732
81st
Division
Manufacturing
529
out of 3,121
83rd
Major group
Chemicals And Allied Products
195
out of 1,416
86th
Industry group
Drugs
175
out of 1,317
87th
Industry
Biological Products, Except Diagnostic Substances
38
out of 291
87th
Source: SEC filing on April 12, 2023.

Kirn's colleagues

We found two more compensation records of executives who worked with David Kirn at 4D Molecular Therapeutics in 2022.

2022

Fariborz Kamal

4D Molecular Therapeutics

Chief Operating Officer

2022

August Moretti

4D Molecular Therapeutics

Chief Financial Officer

News

In-depth

You may also like